10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Emerging technologies are rapidly transforming the landscape of infectious disease management, offering new ways to diagnose, treat, and prevent infections. In recent years, advances such as CRISPR gene editing, rapid point-of-care diagnostics, and artificial intelligence have significantly improved the efficiency of healthcare systems. In the realm of emerging technologies in infectious disease management, wearable devices that monitor health metrics and biosensors capable of detecting pathogens in real-time are becoming essential tools. These technologies not only aid in early detection but also enable personalized treatment plans, allowing for more precise and effective interventions. With continuous innovation, these emerging technologies hold immense potential for improving patient outcomes and combating global infectious disease threats.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria